Prolonged agonist stimulation results in down-regulation of most G protein-coupled receptors. When we exposed baby hamster kidney cells stably expressing the human  1 -adrenergic receptor ( 1 AR) to agonist over a 24-h period, we instead observed an increase of ϳ30% in both  1 AR binding activity and immune-detected receptors. In contrast,  2 AR expressed in these cells exhibited a decrease of >50%. We determined that the basal turnover rates of the two subtypes were similar (t1 ⁄2 ϳ 7 h) and that agonist stimulation increased  2 AR but not  1 AR turnover. Blocking receptor trafficking to lysosomes with bafilomycin A 1 had no effect on basal turnover of either subtype but blocked agonist-stimulated  2 AR turnover. As  1 AR mRNA levels increased in agonist-stimulated cells,  1 AR up-regulation appeared to result from increased synthesis with no change in degradation. To explore the basis for the subtype differences, we expressed chimeras in which the C termini had been exchanged. Each chimera responded to persistent agonist stimulation based on the source of its C-tail;  1 AR with a  2 AR C-tail underwent down-regulation, and  2 AR with a  1 AR C-tail underwent up-regulation. The C-tails had a corresponding effect on agonist-stimulated receptor phosphorylation and internalization with the order being  2 AR >  1 AR with  2 AR C-tail >  2 AR with a  1 AR C-tail >  1 AR. As internalization may be a prerequisite for down-regulation, we addressed this possibility by co-expressing each subtype with arrestin-2. Although  1 AR internalization was increased to that of  2 AR, down-regulation still did not occur. Instead,  1 AR accumulated inside the cells. We conclude that in unstimulated cells, both subtypes appear to be turned over by the same mechanism. Upon agonist stimulation, both subtypes are internalized, and  2 AR but not  1 AR undergoes lysosomal degradation, the fate of each subtype being regulated by determinants in its C-tail.